PTP Accounts Production v23.3.0.418 11464947 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false true false Ordinary Shares 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh114649472022-07-31114649472023-07-31114649472022-08-012023-07-31114649472021-07-31114649472021-08-012022-07-31114649472022-07-3111464947ns10:Originalns15:EnglandWales2022-08-012023-07-3111464947ns14:PoundSterlingns10:Original2022-08-012023-07-3111464947ns10:Originalns10:Director12022-08-012023-07-3111464947ns10:Original2022-08-012023-07-3111464947ns10:Original2023-07-3111464947ns10:Originalns10:PrivateLimitedCompanyLtd2022-08-012023-07-3111464947ns10:Originalns10:SmallEntities2022-08-012023-07-3111464947ns10:Originalns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3111464947ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3111464947ns10:SmallCompaniesRegimeForAccountsns10:Original2022-08-012023-07-3111464947ns10:Originalns10:FullAccounts2022-08-012023-07-3111464947ns10:Originalns10:OrdinaryShareClass12022-08-012023-07-3111464947ns10:Originalns10:Director22022-08-012023-07-3111464947ns10:Originalns10:RegisteredOffice2022-08-012023-07-3111464947ns10:Original2022-07-3111464947ns10:Originalns5:CurrentFinancialInstruments2023-07-3111464947ns10:Originalns5:CurrentFinancialInstruments2022-07-3111464947ns5:ShareCapitalns10:Original2023-07-3111464947ns5:ShareCapitalns10:Original2022-07-3111464947ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-07-3111464947ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-07-3111464947ns10:Originalns5:ComputerEquipment2022-08-012023-07-3111464947ns10:Original2021-08-012022-07-3111464947ns10:Originalns5:ComputerEquipment2023-07-3111464947ns10:Originalns10:OrdinaryShareClass12023-07-31
REGISTERED NUMBER: 11464947 (England and Wales)















FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2023

FOR

MEDICADE LIMITED

MEDICADE LIMITED (REGISTERED NUMBER: 11464947)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


MEDICADE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2023







DIRECTORS: J Cade
Mrs H Cade





REGISTERED OFFICE: 21 Hollowgate
Rotherham
South Yorkshire
S60 2LE





REGISTERED NUMBER: 11464947 (England and Wales)





ACCOUNTANTS: Drury & Co
Accountants & Business Advisors
21 Hollowgate
Rotherham
South Yorkshire
S60 2LE

MEDICADE LIMITED (REGISTERED NUMBER: 11464947)

BALANCE SHEET
31 JULY 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1,158 -

CURRENT ASSETS
Cash at bank 7,344 13,560

CREDITORS
Amounts falling due within one year 5 8,390 12,583
NET CURRENT (LIABILITIES)/ASSETS (1,046 ) 977
TOTAL ASSETS LESS CURRENT
LIABILITIES

112

977

CAPITAL AND RESERVES
Called up share capital 6 100 100
Retained earnings 12 877
SHAREHOLDERS' FUNDS 112 977

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 11 January 2024 and were signed on its behalf by:





Mrs H Cade - Director


MEDICADE LIMITED (REGISTERED NUMBER: 11464947)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2023


1. STATUTORY INFORMATION

Medicade Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

MEDICADE LIMITED (REGISTERED NUMBER: 11464947)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2023


4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
Additions 1,731
At 31 July 2023 1,731
DEPRECIATION
Charge for year 573
At 31 July 2023 573
NET BOOK VALUE
At 31 July 2023 1,158

5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Other creditors 8,390 12,583

6. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
100 Ordinary Shares £1 100 100

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

At the reporting date, the company was indebted the directors in the sum of £7,699. (2022 £11,503)

There are no formal repayment terms attached to this loan and interest is not being charged.